MARAVAI LIFESCIENCES HOLDINGS, INC. Logo

MARAVAI LIFESCIENCES HOLDINGS, INC.

Life sciences company providing nucleic acid production and biologics safety testing.

MRVI | US

Overview

Corporate Details

ISIN(s):
US56600D1072
LEI:
Country:
United States of America
Address:
10770 WATERIDGE CIRCLE SUITE 200, 92121 SAN DIEGO

Description

Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products that enable the development of novel drug therapies, diagnostics, and vaccines. Serving the biopharmaceutical, biotechnology, and academic markets, the company supports customers from discovery through clinical manufacturing. Its operations are focused on two primary areas: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment supplies highly modified nucleic acids, mRNA, and proprietary CleanCap® capping analogs, which are essential for mRNA-based technologies. The Biologics Safety Testing segment, through its Cygnus Technologies brand, provides specialized impurity and contaminant detection kits and services to ensure the safety and purity of biopharmaceutical products, including antibodies, vaccines, and gene therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all MARAVAI LIFESCIENCES HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MARAVAI LIFESCIENCES HOLDINGS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MARAVAI LIFESCIENCES HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.